Quantifying digital vascular disease in patients with primary Raynaud’s phenomenon and systemic sclerosis

In primary and secondary Raynaud’s phenomenon, measurement of activity or severity, or both, of the digital vascular disease is a major challenge. We need to identify objective measures of digital vascular disease that are helpful in predicting those patients with Raynaud’s who have underlying connective tissue disease, and to measure reliably digital vascular disease progression, and responses to treatment. None of the various physiological measurement techniques used in the assessment of patients with primary or secondary Raynaud’s are ideal. In this review we outline these techniques, highlighting their applications and limitations. The discussion concentrates on the physiological assessment of patients with primary Raynaud’s phenomenon (PRP) and systemic sclerosis (SSc), but is also applicable to other connective tissue diseases. We have not included biochemical markers of vascular injury or measurement of tissue oxygen levels. In PRP, episodic ischaemia in response to cold exposure or to emotional stimuli is entirely reversible: absence of tissue damage is a defining feature.1 In contrast, SSc may be associated with irreversible tissue damage with ulceration, scarring and sometimes gangrene, and structural change occurs in the vasculature.2 3 Indeed, SSc is probably primarily a disease of the vasculature, although it is not clear how this interrelates with collagen and other connective tissue matrix metabolism.4 5 Assessment of digital vascular disease needs to take into account: (a) Digital vasospasm. This is best assessed by dynamic testing with standard stimuli, such as a standard cold stress. (b) Structural vascular disease. This may affect basal blood flow in addition to vascular responses to standard stimuli. In the patient presenting with Raynaud’s phenomenon, we must assess both the microvasculature and the digital arteries. Different physiological measurement techniques may be used in combination, especially if investigators wish to examine both digital artery and microvascular flow.6 On widefield capillaroscopy, …

[1]  E. Leroy A brief overview of the pathogenesis of scleroderma (systemic sclerosis). , 1992, Annals of the rheumatic diseases.

[2]  H. Maricq,et al.  Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. , 1986, Microvascular research.

[3]  J. Trafford,et al.  Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenon , 1995, European journal of clinical investigation.

[4]  M. Bartelink,et al.  A standardized finger cooling test for Raynaud's phenomenon: diagnostic value and sex differences. , 1993, European heart journal.

[5]  A. Seifalian,et al.  Comparison of laser Doppler perfusion imaging, laser Doppler flowmetry, and thermographic imaging for assessment of blood flow in human skin. , 1994, European journal of vascular surgery.

[6]  George E. Brown,et al.  RAYNAUD'S DISEASE: A CRITICAL REVIEW OF MINIMAL REQUISITES FOR DIAGNOSIS.* , 1932 .

[7]  D. Veale,et al.  Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. , 1997, Arthritis and rheumatism.

[8]  E. Ring,et al.  Quantitative Thermographic Assessment of Inositol Nicotinate Therapy in Raynaud's Phenomena , 1977, The Journal of international medical research.

[9]  Jacobs Mj,et al.  Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil. , 1985 .

[10]  B. Hazleman,et al.  Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. , 1992, The Journal of rheumatology.

[11]  V. C. Roberts,et al.  Controlled trial of plasma exchange in treatment of Raynaud's syndrome. , 1979, British medical journal.

[12]  C. Bunker,et al.  Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon , 1993, The Lancet.

[13]  A. Hume,et al.  The effect of simple warming procedures on finger blood flow in systemic sclerosis , 1988, The British journal of dermatology.

[14]  T Moore,et al.  Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. , 1996, British journal of rheumatology.

[15]  A. Smit,et al.  Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma. , 1994, Seminars in arthritis and rheumatism.

[16]  M. Bartelink,et al.  Reproducibility of the finger cooling test. , 1993, Microvascular research.

[17]  R. Kester,et al.  Impaired Thermoregulation in Raynaud's Phenomenon , 1995, Angiology.

[18]  D. Walmsley,et al.  Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon. , 1990, British journal of rheumatology.

[19]  T. Moore,et al.  Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. , 1996, British journal of rheumatology.

[20]  P. M. Campbell,et al.  Pathogenesis of systemic sclerosis: a vascular hypothesis. , 1975, Seminars in arthritis and rheumatism.

[21]  E. Cooke,et al.  Photoplethysmography of the Distal Pulp in the Assessment of the Vasospastic Hand , 1985, Angiology.

[22]  Maricq Hr,et al.  Microvasculature in systemic sclerosis. , 1990 .

[23]  V. C. Roberts,et al.  Raynaud's phenomenon and cold stress testing: a new approach. , 1994, European journal of vascular surgery.

[24]  B. Hazleman,et al.  Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin. , 1991, British journal of clinical pharmacology.

[25]  E Michoud,et al.  Digitized nailfold capillaroscopy. , 1994, VASA. Zeitschrift fur Gefasskrankheiten.

[26]  R. Gush,et al.  Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis. , 1989, Scandinavian journal of rheumatology.

[27]  D. Mikhailidis,et al.  Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. , 1991, Clinical science.

[28]  M. Weinrich,et al.  Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders. , 1996, Journal of Rheumatology.

[29]  K. Darton,et al.  Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon. , 1991, British journal of rheumatology.

[30]  E. Ring,et al.  Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. , 1988, Annals of the rheumatic diseases.

[31]  E. Housley,et al.  An evaluation of finger systolic-pressure response to local cooling in the diagnosis of primary Raynaud's phenomenon. , 1985, Clinical physiology.

[32]  M. Engelhart,et al.  The blood supply to fingers during Raynaud's attack: a comparison of laser-Doppler flowmetry with other techniques. , 1985, Clinical physiology.

[33]  J. Kristensen,et al.  Raynaud's phenomenon: blood supply to fingers during indirect cooling, evaluated by laser Doppler flowmetry. , 2008, Clinical physiology.

[34]  J A Allen,et al.  An objective test for the diagnosis and grading of vasospasm in patients with Raynaud's syndrome. , 1992, Clinical science.

[35]  H. Saner,et al.  Local cold exposure test for capillaroscopic examination of patients with Raynaud's syndrome. , 1987, Microvascular research.

[36]  M. F. Martin Prostaglandin E_1 infusion for vascular in sufficiency in progressive systemic sclerosis , 1981 .

[37]  S. Carter,et al.  Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome. , 1988, Circulation.

[38]  F Lefford,et al.  Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. , 1986, Annals of the rheumatic diseases.

[39]  V. Kyle,et al.  Prostaglandin E1 vasospastic disease and thermography. , 1985, Annals of the rheumatic diseases.

[40]  R. Wise,et al.  Reproducibility of cold provocation in patients with Raynaud's phenomenon. , 1987, The Journal of rheumatology.

[41]  M. Jacobs,et al.  Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil. , 1985, International journal of microcirculation, clinical and experimental.

[42]  J. Mikdashi,et al.  The post-occlusive hyperemic response in patients with systemic sclerosis. , 1990, Arthritis and rheumatism.

[43]  E F Ring,et al.  Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. , 1996, Annals of the rheumatic diseases.

[44]  Á. Geirsson,et al.  Functional study of the dermal microcirculation in systemic sclerosis. , 1994, Scandinavian journal of rheumatology.

[45]  H. Maricq,et al.  Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. , 1973, Arthritis and rheumatism.

[46]  G. Rassner,et al.  Local cold exposure test as therapy control in patients with Raynaud's phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries , 1995, The British journal of dermatology.

[47]  S. L. Nielsen Raynaud phenomena and finger systolic pressure during cooling. , 1978, Scandinavian journal of clinical and laboratory investigation.

[48]  H. Wollersheim,et al.  Postocclusive reactive hyperemia of fingertips, monitored by laser Doppler velocimetry in the diagnosis of Raynaud's phenomenon. , 1989, Microvascular research.

[49]  F. Feldman Thermography of the hand and wrist: practical applications. , 1991, Hand clinics.

[50]  M. Goodfield,et al.  Reactive hyperemic responses in systemic sclerosis patients and healthy controls. , 1989, The Journal of investigative dermatology.

[51]  A. Nicolaides,et al.  The effect of local cooling on digital systolic pressure in patients with Raynaud's syndrome , 1982, The British journal of surgery.

[52]  C. Kallenberg,et al.  Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. , 1986, The Journal of rheumatology.

[53]  Limitation of finger systolic pressure measurement as a diagnostic test for primary Raynaud's phenomenon in a female population. , 1989, Clinical physiology.

[54]  W. Siegenthaler,et al.  Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. , 1986, Archives of internal medicine.

[55]  V. C. Roberts,et al.  Digital artery calibre measurement--a new technique of assessing Raynaud's phenomenon. , 1991, European journal of vascular surgery.

[56]  H. Bounameaux,et al.  Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease. , 1990, Journal of Cardiovascular Pharmacology.

[57]  I. Braverman,et al.  Reproducible measurements to quantify cutaneous involvement in scleroderma. , 1995, Archives of dermatology.

[58]  R. Kester,et al.  The Menstrual Cycle and Raynaud's Phenomenon , 1996, Angiology.

[59]  T. Rooke,et al.  Cutaneous laser Doppler flowmetry: applications and findings. , 1994, Mayo Clinic proceedings.

[60]  H. Maricq,et al.  Microvasculature in systemic sclerosis. , 1990, Rheumatic diseases clinics of North America.

[61]  P. A. Lewis,et al.  Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's disease. , 1982, Current medical research and opinion.

[62]  M. Mcilroy,et al.  Doppler ultrasonic investigation of Raynaud's phenomenon: effect of temperature on blood velocity. , 1985, Ultrasound in medicine & biology.

[63]  Zhongping Chen,et al.  Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. , 1997, Optics letters.

[64]  M. Zamora,et al.  Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon , 1990, The Lancet.

[65]  W. Grassi,et al.  Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis. , 1994, British journal of rheumatology.

[66]  M. Jayson,et al.  Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. , 1992, Annals of the rheumatic diseases.

[67]  A. Freemont,et al.  Sequential dermal microvascular and perivascular changes in the development of scleroderma , 1992, The Journal of pathology.

[68]  M. Jayson Systemic sclerosis: a collagen or microvascular disease? , 1984, British medical journal.

[69]  M. Jayson,et al.  Abnormal thermoregulatory responses in patients with reflex sympathetic dystrophy syndrome. , 1994, The Journal of rheumatology.

[70]  J. Seibold,et al.  The Effect of Local Temperature Versus Sympathetic Tone on Digital Perfusion in Raynaud's Phenomenon , 1990, Angiology.

[71]  Toms Sl,et al.  A comparison of the functioning of arteriovenous anastomoses in secondary Raynaud's phenomenon and control subjects in response to local hand warming. , 1995 .

[72]  J P Cooke,et al.  Sex differences in control of cutaneous blood flow. , 1990, Circulation.

[73]  F. Khan,et al.  Digital Blood Flow Response to Body Warming, Cooling, and Rewarming in Patients with Raynaud's Phenomenon , 1995, Angiology.

[74]  E F Ring,et al.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. , 1981, Annals of the rheumatic diseases.

[75]  J. Greve,et al.  Digital Blood Flow in Cooled and Contralateral Finger in Patients with Raynaud's Phenomenon. Comparative Measurements Between Photoelectrical Plethysmography and Laser Doppler Flowmetry , 1992, Angiology.

[76]  P Lee,et al.  Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. , 1983, The Journal of rheumatology.

[77]  T Moore,et al.  Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon. , 1995, British journal of rheumatology.

[78]  V. C. Roberts,et al.  Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: a hormonal basis to Raynaud's phenomenon? , 1985, Clinical science.